Atlas Trials

A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)

Clinical trial NCT01208207 · COMPLETED

Trial details

NCT number
NCT01208207
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Spondylitis, Ankylosing
Start date
2010-09-27
Primary completion
2014-11-12
Enrollment
1015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.